Huy Q. Dinh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Huy Q. Dinh has a total of 504 co-authors. Here are the top co-authors by number of shared publications:
- Joshua Brand
University of Wisconsin 2 McArdle Laboratory for Cancer Research, Department of Oncology Madison, Wisconsin
26 shared publications - Parth Khatri
McArdle Laboratory for Cancer Research, Department of Oncology, Carbone Cancer Center, University of Wisconsin-Madison, Madison, USA
24 shared publications - Athena E. Golfinos
McArdle Laboratory for Cancer Research, Department of Oncology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin
22 shared publications - Paul F. Lambert
McArdle Laboratory for Cancer Research, School of Medicine and Public Health, University of Wisconsin-Madison
21 shared publications - Taja Lozar
McArdle Laboratory for Cancer Research, Department of Oncology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin
21 shared publications - Dana Carina Baiu
Department of Medical Microbiology and Immunology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin
20 shared publications
Latest Publications
- 11 November 2026
- Published by Elsevier in Cancer Letters
Differential myeloma progression and response to TIGIT immune checkpoint blockade in Vk*MYC; NrasQ61R mice
- 11 November 2026
- Published by Elsevier in Cancer Letters
Differential myeloma progression and response to TIGIT immune checkpoint blockade in Vk*MYC; NrasQ61R mice
- Open Access
- 30 July 2026
- Published by Springer Nature in The EMBO Journal
- Vol. 45 (17) , 6229-6266
NF-κB/RelA signaling required for CD40-induced humoral immunity depends on specific NEMO lysine residues in mice
Oxidative stress and genotoxic damage activate NF-κB signaling through intracellular pathways distinct from those initiated by membrane receptors. DNA damage selectively induces post-translational modifications at lysine residues 277 and 309 of the human ubiquitin-binding protein NEMO to promote NF-κB signaling, but the physiological importance of these modifications in vivo remains unclear. Here, we show that a newly developed mouse model (NEMO DK ) carrying germline arginine substitutions of the corresponding NEMO lysine residues exhibits B-cell-intrinsic defects in germinal center formation and anti-viral humoral responses. Mechanistically, we identify in NEMO DK B-cells a CD40-specific NF-κB signaling defect that is not linked to the well-characterized canonical or noncanonical NF-κB pathways. These B-cells fail to secure sustained NEMO monoubiquitination following CD40-induced ROS generation, which specifically reduces downstream RelA (p65) signaling required for the transcriptomic and epigenetic remodeling underlying homotypic B-cell aggregation, cell proliferation, class-switch recombination, and antibody-secreting cell generation. Our results establish a physiological role of murine NEMO K270 and K302 in linking CD40 engagement to B-cell responses through enabling sustained NEMO modification and RelA transcriptional activity.
- 30 July 2026
- Published by Springer Nature in The EMBO Journal
- Vol. 45 (17) , 6229-6266
Open AccessNF-κB/RelA signaling required for CD40-induced humoral immunity depends on specific NEMO lysine residues in mice
Oxidative stress and genotoxic damage activate NF-κB signaling through intracellular pathways distinct from those initiated by membrane receptors. DNA damage selectively induces post-translational modifications at lysine residues 277 and 309 of the human ubiquitin-binding protein NEMO to promote NF-κB signaling, but the physiological importance of these modifications in vivo remains unclear. Here, we show that a newly developed mouse model (NEMO DK ) carrying germline arginine substitutions of the corresponding NEMO lysine residues exhibits B-cell-intrinsic defects in germinal center formation and anti-viral humoral responses. Mechanistically, we identify in NEMO DK B-cells a CD40-specific NF-κB signaling defect that is not linked to the well-characterized canonical or noncanonical NF-κB pathways. These B-cells fail to secure sustained NEMO monoubiquitination following CD40-induced ROS generation, which specifically reduces downstream RelA (p65) signaling required for the transcriptomic and epigenetic remodeling underlying homotypic B-cell aggregation, cell proliferation, class-switch recombination, and antibody-secreting cell generation. Our results establish a physiological role of murine NEMO K270 and K302 in linking CD40 engagement to B-cell responses through enabling sustained NEMO modification and RelA transcriptional activity.
- Open Access
Spatial Autocorrelation Aware Resampling Improves Cell-Cell Interaction Inference in Spatial Transcriptomics Data
Spatial transcriptomics has enabled finer-grained analyses of cell-cell interactions through the co-expression of ligands and their cognate receptors, thereby accounting for the spatial constraints of signaling. However, existing methods employ random permutations or analytic calculations to assess statistical significance, neither of which accounts for spatial autocorrelation, a common property of spatially resolved data. Here, we introduce SOAAR (Spatial Omics Autocorrelation-Aware Resampling), a statistical method for testing gene-gene correlations in spatial data that maintains spatial gene-level autocorrelation in resampled datasets used to generate null distributions. SOAAR uses spatial map patterns to decompose autocorrelation. The associations between gene expression and autocorrelation patterns are then randomized to construct resampled datasets used for evaluating significance testing. We showed that SOAAR maintains gene-level spatial autocorrelation and yields a lower false-positive rate than random permutations across varying degrees of gene-level spatial autocorrelation in simulation studies. In a 10X Visium dataset from 10 HNSCC patients treated with immunotherapy, SOAAR filters out low-confidence interactions that were present in only individual samples or in fewer than 3 samples. That led to the identification of a consistent signature of T-cell recruitment in Responder patients and a resistance signature driven by angiogenesis and tumor cell proliferation in Non-Responders. Similar trends were observed in a larger cohort of 23 patients profiled with single-cell spatial CosMX SMI data, revealing immune cell interactions in response to immunotherapy. Overall, SOAAR provides a more calibrated framework for testing spatial correlation, grounded in spatial statistics. Future developments will seek to link localized correlation patterns to downstream changes in biological pathways, thereby informing biomarker and therapeutic target discovery.
Open AccessSpatial Autocorrelation Aware Resampling Improves Cell-Cell Interaction Inference in Spatial Transcriptomics Data
Spatial transcriptomics has enabled finer-grained analyses of cell-cell interactions through the co-expression of ligands and their cognate receptors, thereby accounting for the spatial constraints of signaling. However, existing methods employ random permutations or analytic calculations to assess statistical significance, neither of which accounts for spatial autocorrelation, a common property of spatially resolved data. Here, we introduce SOAAR (Spatial Omics Autocorrelation-Aware Resampling), a statistical method for testing gene-gene correlations in spatial data that maintains spatial gene-level autocorrelation in resampled datasets used to generate null distributions. SOAAR uses spatial map patterns to decompose autocorrelation. The associations between gene expression and autocorrelation patterns are then randomized to construct resampled datasets used for evaluating significance testing. We showed that SOAAR maintains gene-level spatial autocorrelation and yields a lower false-positive rate than random permutations across varying degrees of gene-level spatial autocorrelation in simulation studies. In a 10X Visium dataset from 10 HNSCC patients treated with immunotherapy, SOAAR filters out low-confidence interactions that were present in only individual samples or in fewer than 3 samples. That led to the identification of a consistent signature of T-cell recruitment in Responder patients and a resistance signature driven by angiogenesis and tumor cell proliferation in Non-Responders. Similar trends were observed in a larger cohort of 23 patients profiled with single-cell spatial CosMX SMI data, revealing immune cell interactions in response to immunotherapy. Overall, SOAAR provides a more calibrated framework for testing spatial correlation, grounded in spatial statistics. Future developments will seek to link localized correlation patterns to downstream changes in biological pathways, thereby informing biomarker and therapeutic target discovery.
- Open Access
Single-cell multi-omics analysis reveals heterogeneity and plasticity of neutrophil states in response to immunotherapies
Background: Tumor-associated neutrophils (TANs) are emerging as functionally heterogeneous and plastic cells in the tumor microenvironment. In immunologically cold tumors, elevated neutrophil abundance correlates with poor prognosis and resistance to immune checkpoint inhibition (ICI). Whether distinct anti-tumoral neutrophil states can be induced by different immunotherapies, and how they relate to treatment efficacy remains unclear. Methods: Using the syngeneic MOC2-huEGFR (M2h) mouse model of head and neck squamous cell cancer (HNSCC), we treated tumor-bearing mice with agonistic anti-CD40 monoclonal antibody (mAb) (aCD40), TNFα, Cetuximab, or a combination of all three, designated Neutrophil Activating Therapy (NAT). In addition to evaluating anti-tumor efficacy, we performed single-cell multiomics RNA and protein sequencing, followed by bioinformatics analyses and flow cytometry validation. NAT-induced anti-tumor efficacy and related neutrophil states were also assessed in another cold tumor model, 9464D-GD2 neuroblastoma. Murine treatment-induced neutrophil gene signatures were then evaluated using clinical, proteomic, and transcriptomic data from HNSCC patients. Results: Five transcriptionally distinct neutrophil states (N0-N4), including precursor state CD49d+ N4, were identified using the M2h model. N0 neutrophils (immunosuppressive/quiescent) dominated untreated tumors, but not in successful treatments. ISG+ N1 neutrophils and CCR3+ N3 neutrophils expanded by aCD40, TNFα, and NAT treatment with anti-tumoral gene signatures and found more interacting with CD8+ T cells from bioinformatics analysis. N2 neutrophils reflected a recently established hypoxia-adapted state found in all treatments. ICAM1 (CD54) emerged as a marker of treatment-induced neutrophil activation, discriminating N1, N2, and N3 neutrophils from N0 neutrophils, validated by flow cytometry. In the 9464D-GD2 neuroblastoma model, NAT treatment also reduced the N0 dominance seen in untreated tumors in the HNSCC model but failed to induce anti-tumoral neutrophil states. In 23 HNSCC patients who received ICI therapy, ICAM1 protein expression in neutrophils trended toward association with responder status (TMA-level p=0.029), and ICAM1 neutrophil gene expression also trended toward association with improved overall survival in TCGA data (HR=0.75, p=0.059). Conclusions: Distinct immunotherapy-induced neutrophil states are defined by transcriptional profiles enriched in different functional pathways, associated with both anti-tumor and pro-tumor signatures. ICAM1 identifies activated neutrophils and potentially serves as a biomarker of ICI response in HNSCC, warranting further clinical validation.
Open AccessSingle-cell multi-omics analysis reveals heterogeneity and plasticity of neutrophil states in response to immunotherapies
Background: Tumor-associated neutrophils (TANs) are emerging as functionally heterogeneous and plastic cells in the tumor microenvironment. In immunologically cold tumors, elevated neutrophil abundance correlates with poor prognosis and resistance to immune checkpoint inhibition (ICI). Whether distinct anti-tumoral neutrophil states can be induced by different immunotherapies, and how they relate to treatment efficacy remains unclear. Methods: Using the syngeneic MOC2-huEGFR (M2h) mouse model of head and neck squamous cell cancer (HNSCC), we treated tumor-bearing mice with agonistic anti-CD40 monoclonal antibody (mAb) (aCD40), TNFα, Cetuximab, or a combination of all three, designated Neutrophil Activating Therapy (NAT). In addition to evaluating anti-tumor efficacy, we performed single-cell multiomics RNA and protein sequencing, followed by bioinformatics analyses and flow cytometry validation. NAT-induced anti-tumor efficacy and related neutrophil states were also assessed in another cold tumor model, 9464D-GD2 neuroblastoma. Murine treatment-induced neutrophil gene signatures were then evaluated using clinical, proteomic, and transcriptomic data from HNSCC patients. Results: Five transcriptionally distinct neutrophil states (N0-N4), including precursor state CD49d+ N4, were identified using the M2h model. N0 neutrophils (immunosuppressive/quiescent) dominated untreated tumors, but not in successful treatments. ISG+ N1 neutrophils and CCR3+ N3 neutrophils expanded by aCD40, TNFα, and NAT treatment with anti-tumoral gene signatures and found more interacting with CD8+ T cells from bioinformatics analysis. N2 neutrophils reflected a recently established hypoxia-adapted state found in all treatments. ICAM1 (CD54) emerged as a marker of treatment-induced neutrophil activation, discriminating N1, N2, and N3 neutrophils from N0 neutrophils, validated by flow cytometry. In the 9464D-GD2 neuroblastoma model, NAT treatment also reduced the N0 dominance seen in untreated tumors in the HNSCC model but failed to induce anti-tumoral neutrophil states. In 23 HNSCC patients who received ICI therapy, ICAM1 protein expression in neutrophils trended toward association with responder status (TMA-level p=0.029), and ICAM1 neutrophil gene expression also trended toward association with improved overall survival in TCGA data (HR=0.75, p=0.059). Conclusions: Distinct immunotherapy-induced neutrophil states are defined by transcriptional profiles enriched in different functional pathways, associated with both anti-tumor and pro-tumor signatures. ICAM1 identifies activated neutrophils and potentially serves as a biomarker of ICI response in HNSCC, warranting further clinical validation.
- Open Access
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S5B from Integrated Single-Cell and Spatial Analysis Reveals Context-Dependent Myeloid–T Cell Interactions in Response to Immune Checkpoint Blockade in Head and Neck Cancer
Spatially defined neighborhoods distribution (RNA) in each TMA FOVs for Non-Responders
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S5B from Integrated Single-Cell and Spatial Analysis Reveals Context-Dependent Myeloid–T Cell Interactions in Response to Immune Checkpoint Blockade in Head and Neck Cancer
Spatially defined neighborhoods distribution (RNA) in each TMA FOVs for Non-Responders
- Open Access
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S4 from Integrated Single-Cell and Spatial Analysis Reveals Context-Dependent Myeloid–T Cell Interactions in Response to Immune Checkpoint Blockade in Head and Neck Cancer
Supplementary Figure 4. Identification of spatial cellular neighborhoods in CosMX data.
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4 from Integrated Single-Cell and Spatial Analysis Reveals Context-Dependent Myeloid–T Cell Interactions in Response to Immune Checkpoint Blockade in Head and Neck Cancer
Supplementary Figure 4. Identification of spatial cellular neighborhoods in CosMX data.
- Open Access
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S3 from Integrated Single-Cell and Spatial Analysis Reveals Context-Dependent Myeloid–T Cell Interactions in Response to Immune Checkpoint Blockade in Head and Neck Cancer
Supplementary Figure 3. Supporting data of multi-modality data profiles of HNSCC tumors.
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from Integrated Single-Cell and Spatial Analysis Reveals Context-Dependent Myeloid–T Cell Interactions in Response to Immune Checkpoint Blockade in Head and Neck Cancer
Supplementary Figure 3. Supporting data of multi-modality data profiles of HNSCC tumors.
- Open Access
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S2 from Integrated Single-Cell and Spatial Analysis Reveals Context-Dependent Myeloid–T Cell Interactions in Response to Immune Checkpoint Blockade in Head and Neck Cancer
Supplementary Figure 2. Overview of 3 TMA core distribution. Recapture of captured area in protein and RNA assay of three TMAs (red - protein, blue - RNA)
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from Integrated Single-Cell and Spatial Analysis Reveals Context-Dependent Myeloid–T Cell Interactions in Response to Immune Checkpoint Blockade in Head and Neck Cancer
Supplementary Figure 2. Overview of 3 TMA core distribution. Recapture of captured area in protein and RNA assay of three TMAs (red - protein, blue - RNA)
- Open Access
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S7 from Integrated Single-Cell and Spatial Analysis Reveals Context-Dependent Myeloid–T Cell Interactions in Response to Immune Checkpoint Blockade in Head and Neck Cancer
Identification of Ligand-Receptor co-expression in Visium data.
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S7 from Integrated Single-Cell and Spatial Analysis Reveals Context-Dependent Myeloid–T Cell Interactions in Response to Immune Checkpoint Blockade in Head and Neck Cancer
Identification of Ligand-Receptor co-expression in Visium data.
- Open Access
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S9 from Integrated Single-Cell and Spatial Analysis Reveals Context-Dependent Myeloid–T Cell Interactions in Response to Immune Checkpoint Blockade in Head and Neck Cancer
Identification of Ligand-Receptor in cell type pair interactions from scRNA-Seq.
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S9 from Integrated Single-Cell and Spatial Analysis Reveals Context-Dependent Myeloid–T Cell Interactions in Response to Immune Checkpoint Blockade in Head and Neck Cancer
Identification of Ligand-Receptor in cell type pair interactions from scRNA-Seq.